NAD Recommends Nordic US Discontinue Certain Claims for ‘Hair Volume’
New York, NY – July 25, 2013 – The National Advertising Division has recommended that New Nordic US, Inc. modify or discontinue claims for the company’s Hair Volume dietary supplement, including claims that suggest use of the product could reverse balding in women.
NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus.
As part of its ongoing monitoring program and in conjunction with an initiative with The Council for Responsible Nutrition designed to expand NAD’s review of advertising claims for dietary supplements, NAD requested the advertiser provide substantiation for certain claims made in Internet and print advertising.
NAD examined express claims that included:
- “Hair Volume is based on vitamins, minerals and innovative hair growth from apples. The composition is a unique innovation and reinvention of the old hair, skin and nail tablet.”
- “Thousands of people have already experienced the benefits of Hair Volume, which has made it the world’s leading hair tablet with natural apple hair growth factor.”
- “Hair Volume is a new Scandinavian invention.”
- “Strengthens your hair. With hair growth factors and minerals for hair follicles, skin and nails.”
NAD also reviewed the following testimonial: “I started taking the new Hair Volume tablets and the transformation was incredible. My hair appeared with more thickness, more life. It feels fuller and looks more vibrant and healthier…Even my nails are stronger. All this with one tablet a day. This is proof to me that with the right nutrients you don’t have to accept your family fate…Hair volume is the proof.”
NAD further considered whether the advertising at issue implied that use of the product would reverse balding, even genetic pattern baldness, in women.
Following its review of the evidence in the record, NAD recommended that the advertiser discontinue the claims at issue, including the testimonial.
The company, in its advertiser’s statement, said that while “we felt we had some substantiation from the clinical studies of our ingredients, we wish to work with you to correctly advertise our product and thus accept to adhere to the above in our advertising of Hair Volume.”
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
Latest Decisions
National Advertising Division Recommends Oral Essentials Discontinue "Certified Non-Toxic" Claim for its Lumineux Mouthwash
New York, NY – December 30, 2024 – In a Fast-Track SWIFT challenge brought by GuruNanda, the National Advertising Division recommended that Oral Essentials discontinue its claim that Lumineux mouthwash products are “Certified Non-Toxic.”
NARB Recommends T-Mobile Discontinue or Modify Commercial to Better Disclose Conditions of Free iPhone Offer, 20% Savings Claim
New York, NY – December 30, 2024 – A panel of the National Advertising Review Board (NARB) recommended that T-Mobile discontinue or modify its commercial to better disclose the material conditions of its free iPhone 16 Pro offer and its 20% rate plan savings claim compared to AT&T and Verizon.
Direct Selling Self-Regulatory Council Recommends Valentus Discontinue Earnings and Product Performance Claims
McLean, VA – December 23, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended Valentus, a direct selling company that sells nutritional and lifestyle products, discontinue earnings and health-related product performance claims made on social media and on the Valentus website.
Direct Selling Self-Regulatory Council Refers Olive Tree Earnings Claims to the FTC and California AG for Possible Enforcement Action
McLean, VA – December 20, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) referred Olive Tree to the Federal Trade Commission (FTC) and California Attorney General's Office for possible enforcement action after Olive Tree failed to respond to a DSSRC inquiry into earnings claims.